导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 43.98% | 60/1050 |
| 近一周 | -0.33% | 51/1104 |
| 近一月 | -4.65% | 569/1102 |
| 近一季 | -18.79% | 940/1092 |
| 近半年 | 19.19% | 153/1070 |
| 近一年 | 49.51% | 77/1018 |
| 近两年 | 185.55% | 68/926 |
| 近三年 | 133.70% | 66/834 |
| 成立以来 | 306.88% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
11.14% 38/1070 |
80.29% 106/1101 |
- - |
- - |
| 2025 | 42.73% 285/1065 |
11.08% 125/1014 |
-1.15% 785/1038 |
28.69% 380/1050 |
1.01% 397/1065 |
| 2024 | 12.94% 219/1011 |
-4.34% 546/960 |
-4.00% 573/983 |
10.84% 564/991 |
10.95% 60/1011 |
| 2023 | -3.01% 159/952 |
8.58% 158/880 |
-2.07% 305/895 |
-8.83% 545/915 |
0.06% 121/952 |
| 2022 | -20.70% 352/867 |
-21.81% 629/773 |
8.76% 310/806 |
-9.33% 203/845 |
2.84% 282/867 |
| 2021 | 29.04% 77/740 |
-3.15% 275/580 |
13.89% 258/659 |
1.79% 189/704 |
14.94% 24/740 |
| 2020 | 55.46% 215/554 |
-9.10% 371/419 |
30.95% 116/466 |
18.77% 68/517 |
9.96% 360/554 |
| 2019 | 41.78% 207/410 |
24.02% 780/1149 |
-5.53% 746/1231 |
6.77% 169/390 |
13.34% 84/410 |
| 2018 | -29.23% 204/349 |
- - |
- - |
- - |
-11.43% 457/1080 |
| 2017 | 23.16% 73/285 |
- - |
- - |
- - |
- - |
| 2016 | -11.26% 70/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 国寿安保智慧生活股票 VS. 东吴新产业精选股票A(580008) |